COMMUNIQUÉS West-GlobeNewswire

Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/12/2017 - 22:30

BURLINGTON, Mass., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to three new employees for an aggregate of 20,500 shares of common [...]

Dova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting

04/12/2017 - 22:30

DURHAM, N.C., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that the Company will present four abstracts, three of which will be oral presentations, with data from Phase 3 [...]

Vital Therapies Appoints Russell J. Cox as Chief Executive Officer and Board Member Effective January 3, 2018

04/12/2017 - 22:29

SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced [...]

Five Prime Therapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference

04/12/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]

TRACON Pharmaceuticals Announces Appointment of Brian Daniels, M.D., to Scientific Advisory Board

04/12/2017 - 22:05

SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

BeiGene to Webcast an Analyst and Investor Event from the American Society of Hematology Annual Meeting

04/12/2017 - 22:05

CAMBRIDGE, Mass., and BEIJING, China, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017

04/12/2017 - 22:05

TUSTIN, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company focused on helping improve patient lives by providing high quality biologics manufacturing [...]

Opiant Pharmaceuticals, Inc. Reports Fiscal First Quarter 2018 Financial Results

04/12/2017 - 22:05

SANTA MONICA, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported [...]

Adamis Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose

04/12/2017 - 22:05

SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) (“Adamis”) announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug [...]

Sunesis Pharmaceuticals Announces Change in Leadership

04/12/2017 - 22:05

- Daniel Swisher Resigns as CEO Effective End of 2017; t o Remain with Sunesis as a Strategic Advisor - - Board Member Dayton Misfeldt Appointed Interim CEO Effective January 2018; Board Starting Retained Search for [...]

Tabula Rasa HealthCare Announces Proposed Offering of Common Stock

04/12/2017 - 22:01

MOORESTOWN, N.J., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ) (“TRHC”), a healthcare technology optimizing medication safety by deploying new medication risk mitigation digital [...]

Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting

04/12/2017 - 22:01

BURNABY, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ: XENE ), a clinical-stage biopharmaceutical company, today announced the presentation of a scientific poster entitled “ [...]

Allscripts to attend upcoming investor events

04/12/2017 - 22:01

CHICAGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) today announced that certain members of its management team will attend the following upcoming investor events: Citi Global Mizuho Investor [...]

Akari Therapeutics to Host Investor and Analyst Event During the 59th American Society of Hematology Meeting

04/12/2017 - 22:01

NEW YORK and LONDON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan [...]

Galectin Therapeutics to Present Results from Phase 2b NASH-CX Trial on December 5, 2017

04/12/2017 - 22:00

NORCROSS, Ga., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, will issue a press release announcing the results of its [...]

VALNEVA to Conduct Investor and Partnering Meetings during the Annual J.P. Morgan Healthcare Conference

04/12/2017 - 19:01

Valneva to Conduct Investor and Partnering Meetings during the Annual J.P. Morgan Healthcare Conference Lyon (France), December 4, 2017 - Valneva SE today announces that its senior management team will hold investor and [...]

VALNEVA rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference

04/12/2017 - 19:01

Valneva rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference Lyon (France), 4 décembre 2017 - Valneva SE annonce ce jour que son équipe dirigeante rencontrera investisseurs et [...]

Progressive Care Announces Uplist to OTCQB

04/12/2017 - 17:35

MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]

Ossur Hf : Transactions in relation to share buyback program

04/12/2017 - 17:01

Announcement from Össur hf. No. 85/2017 Reykjavík, 4 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]